Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:02 AM
Study NCT ID:
NCT06206902
Status:
RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-12-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Sponsor:
Shanghai Simnova Biotechnology Co.,Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-18
First Submit QC Date:
None
Study First Post Date:
2024-01-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL